Clinical Trial Detail

NCT ID NCT03319901
Title Venetoclax and Chemotherapy In ALL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine

Mercaptopurine

Methotrexate

Cyclophosphamide

Venetoclax

Doxorubicin

Etoposide

Vincristine Sulfate

Age Groups: adult senior

No variant requirements are available.